Single-dose pharmacokinetics of roflumilast in children and adolescents.
about
Recent new drug approvals, part 2: drugs undergoing active clinical studies in childrenEfficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor.Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD.
P2860
Single-dose pharmacokinetics of roflumilast in children and adolescents.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Single-dose pharmacokinetics of roflumilast in children and adolescents.
@en
Single-dose pharmacokinetics of roflumilast in children and adolescents.
@nl
type
label
Single-dose pharmacokinetics of roflumilast in children and adolescents.
@en
Single-dose pharmacokinetics of roflumilast in children and adolescents.
@nl
prefLabel
Single-dose pharmacokinetics of roflumilast in children and adolescents.
@en
Single-dose pharmacokinetics of roflumilast in children and adolescents.
@nl
P2093
P2860
P356
P1476
Single-dose pharmacokinetics of roflumilast in children and adolescents.
@en
P2093
Gezim Lahu
Gregory L Kearns
Kathleen A Neville
Melanie C Gleason
Rolf Herzog
Susan M Abdel-Rahman
Thomas D Bethke
P2860
P304
P356
10.1177/0091270008319466
P577
2008-05-28T00:00:00Z